ERS Publications Podcasts

As part of the April issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Martin Kolb interviews Andreas von Leupoldt (University of Leuven, Belgium) and Thomas Similowski (Sorbonne Universités and Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Paris, France) about how observing dyspnoea in others elicits dyspnoea, negative affect and brain respon...

As part of the March issue, the European Respiratory Journal presents the latest in its series of podcasts. To mark World TB Day, chief editor Martin Kolb interviews section editor Giovanni Battista Migliori about the following articles. ---- Borisov SE, Dheda K, Enwerem M, et al. Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study....

As part of the February issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Martin Kolb interviews Jørgen Vestbo (The University of Manchester and Manchester University NHS Foundation Trust, Manchester, UK) about the important difference between standard efficacy trials and real-world effectiveness trials such as the Salford Lung Study.

As part of the January issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy chief editor James Chalmers interviews the Anthony De Soyza (Newcastle University, Newcastle, UK) and Timothy Aksamit (Mayo Clinic, Rochester, MN, USA) about the RESPIRE1 and RESPIRE2 trials of ciprofloxacin in non-cystic fibrosis bronchiectasis. These two global phase III trials en...

As part of the December issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert interviews the incoming Chief Editor Martin Kolb and Deputy Chief Editor James Chalmers about the future of the ERJ, and reflects on his own time as Chief Editor.

As part of the November issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert discusses the ERS statement on the diagnosis and treatment of pulmonary disease caused by α1-antitrypsin deficiency with Task Force chairs Marc Miravitlles (Hospital Universitari Vall d’Hebron, Barcelona, Spain) and Robert A. Stockley (Queen Elizabeth Hospital, B...

As part of the October issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert discusses the lessons learned from clinical trials in idiopathic pulmonary fibrosis over the past 25 years with Prof. Ganesh Raghu from the University of Washington, Seattle, WA, USA.

As part of the September issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert discusses the publication of the results of a survey of patients with severe asthma with Prof. Helen K. Reddel from the University of Sydney, Sydney, and the NHMRC Centre for Research Excellence in Severe Asthma, Newcastle, Australia.

As part of the August issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert discusses the publication of the results of a trial of fevipiprant, an oral prostaglandin in DP2 receptor (CRTh2) antagonist, in allergic asthma that is not controlled by low-dose inhaled corticosteroids with Prof. Eric D. Bateman from the University of Cape Town,...